In our study, S1PR1 and S1PR4 were the main receptors expressed in asthmatic PBMCs, while S1PR4 was the only elevated receptor after standardized management and treatment of asthma, indicating to a predictable effect on the pathophysiology of asthma, especially in the immune response. This evidence concerns the gene S1PR4 and asthma.